Full Text View
Tabular View
No Study Results Posted
Related Studies
Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)
This study is currently recruiting participants.
Study NCT00524615   Information provided by University Hospital Olomouc
First Received: August 31, 2007   Last Updated: February 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
spironolactone
Additional drug interventions recognized in this trial
Aldosterone Antagonists
More general drug interventions related to this trial
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University Hospital Olomouc
Czech Society of Hypertension
Sternberk Hospital
Brno University Hospital
Olomouc Military Hospital
Gedeon Richter Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services